PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

ChemAxon and AWS simplify getting scientists moving on the cloud

Paul Underwood, solution architect at Amazon Web Services (AWS), introduced the Biotech Blueprint QuickStart program on ChemAxon’s user meeting in Boston last April. The presentation starts with a brief overview of a typical informatics infrastructure and platform teams working at biotech companies.

Paul concluded that generally the teams, dedicated to create and maintain the core platform of a biotech have to face the following challenges:

  • Resource issues – either small teams or expensive consultancy services
  • Fast reaction – science urges new solutions to happen swiftly
  • Create easy, everywhere available platforms – that is move everything to the cloud.

This need moved AWS to launch their Biotech Blueprint project. The goal is to build a secure, cloud-based platform solution that allows its users to set-up and configure best-of-breed software solutions needed throughout the drug discovery process. To achieve this, AWS provides the knowledge and expertise of a secure cloud platform; and it integrates selected software vendors to cover different scientific fields.

The project started with the needs of the preclinical phase. In the chemistry field ChemAxon got selected as the top vendor to provide unambiguous, novel compound registration within the project. Paul Underwood thanked ChemAxon for “being a leader in the cloud and being a Biotech Blueprint Launch Partner.”

AWS recently has launched Biotech Blueprint, that offers an easy switch to a cloud platform. Based on initial test results the deployment process got shrinked from weeks to only 15 minutes. The biotech company’s platform team only has to click on the required software solution and upload and install the license.

Listen to the talk by Paul Underwood of AWS [https://chemaxon.com/presentation/biotech-blueprint-how-chemaxon-and-aws-simplify-getting-you-moving-on-the-cloud] introducing Biotech Blueprint. And contact ChemAxon [https://chemaxon.com/] for more details.

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40